Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38098

Arl8a Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The ARL8A Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting ARL8A, a lysosomal small GTPase that controls lysosome trafficking and positioning in HEK293T human embryonic kidney epithelial cells. ARL8A cycles between GDP- and GTP-bound states, and in its active form recruits the adaptor SKIP to link lysosomes to kinesin-1 motors for anterograde transport, while also interacting with the HOPS complex to drive autophagosome?Clysosome fusion and mTORC1 nutrient sensing. This knockout model is applied to dissect lysosomal positioning in autophagy, neurodegeneration, and cancer cell migration, and to screen for chemical modulators of lysosomal trafficking. Representative techniques include immunofluorescence, live-cell imaging, western blot for LC3-II and p62, co-immunoprecipitation of ARL8A?CSKIP, and LysoTracker-based pH measurements.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ARL8A

    Gene Identifier

    NCBI Gene ID 127829

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ARL8A Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population generated for loss-of-function analysis of the lysosomal small GTPase ARL8A. This polyclonal model provides a heterogeneous cell pool with disrupted ARL8A expression, enabling functional studies without clonal selection bias. The CRISPR/Cas9-mediated gene disruption targets the ARL8A locus, delivering a versatile system for investigating ARL8A-dependent cellular processes.

HEK293T cells are human embryonic kidney epithelial cells that stably express the SV40 large T antigen, conferring exceptional transfection efficiency and protein production capacity. Derived from the HEK293 lineage, this adherent cell line is a standard host for viral packaging, transient expression, and biochemical assays. The epithelial background provides a well-characterized platform to examine intracellular trafficking, including lysosome dynamics and autophagy flux.

ARL8A functions as a lysosome-resident small GTPase that cycles between GDP- and GTP-bound states to control lysosomal positioning and trafficking. In its active GTP-bound form, ARL8A recruits the adaptor SKIP (PLEKHM2), which couples lysosomes to the microtubule motor kinesin-1 (KIF5B) via kinesin light chain 1 (KLC1), driving anterograde transport toward the cell periphery. ARL8A also interacts with the HOPS complex subunits VPS18 and VPS39 to facilitate autophagosome?Clysosome fusion. This trafficking function is essential for mTORC1 signaling, as peripheral lysosome positioning is required for nutrient-dependent mTORC1 activation. ARL8A is regulated by GTP binding and the BORC complex, integrating upstream signals from Rab7 to coordinate lysosomal motility with cellular metabolism.

In HEK293T cells, ARL8A disruption leads to defective lysosomal anterograde transport, resulting in perinuclear accumulation of lysosomes, a phenotype easily scored by immunofluorescence. This mislocalization impairs autophagosome?Clysosome fusion and attenuates mTORC1 activity, providing a direct cell model to link lysosome positioning with autophagy and nutrient sensing. The polyclonal nature of the knockout pool preserves the genetic heterogeneity of the parental line, allowing robust assessment of ARL8A??s role in cellular processes such as cell migration, where lysosome positioning influences focal adhesion dynamics.

Applications include immunofluorescence staining for lysosomal markers, live-cell imaging of lysosome motility, and western blot analysis of autophagy substrates LC3-II and p62. Co-immunoprecipitation experiments can validate ARL8A??s interaction with SKIP, and GTPase activity assays directly measure ARL8A activation. Lysosomal pH monitoring with LysoTracker or cell migration/invasion assays extend the utility to drug screening and motility studies. This polyclonal knockout cell population is well-suited for chemical modifier screens and for dissecting lysosome-dependent signaling pathways. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)